FMR LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,114,369 9.067% | -114,701 (-2.19%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,229,070 9.271% | -126,873 (-2.37%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,355,943 9.496% | -19,180 (-0.36%) | Filing |
| 2021-05-10 1:11 pm Purchase | 2021-05-07 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,375,123 10.000% | 33,514 (+0.63%) | Filing |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,341,609 9.999% | -120 (-0.00%) | Filing |
| 2020-12-10 09:15 am Purchase | 2020-12-09 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,341,729 10.000% | 567,776 (+11.89%) | Filing |
| 2020-02-07 11:12 am Purchase | 2020-02-06 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 4,773,953 9.999% | 570,707 (+13.58%) | Filing |